# Shanghanlun (Shenzhen) Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghanlun-shenzhen-biotechnology-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Latest round: Angel (Apr 6, 2022)
- Investors on record: 1

## About

Established in 2021 and based in Shenzhen, China, Shanghanlun (Shenzhen) Biotechnology Co., Ltd. is a healthcare and biotechnology company that focuses on the development of molecular diagnostics. In April 2022, the company raised an undisclosed amount of angel funding from new investor.

The company's main business is the research and development and production of molecular diagnostic enzymes with excellent performance and stability. The company self-developed products include industrial grade antibody-modified Taqase, chemically modified Taqase, heat-sensitive UDGase, reverse transcriptase and murine-derived Rnase inhibitor.

The company plans to use the angel funding to development and mass production of industrial-grade molecular diagnostic enzymes, construction of mammalian cell expression systems, cell-free expression systems.

## Funding rounds

- Angel, Apr 6, 2022 — YuanBio Venture

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Angel